Sleep News and Research

Latest Sleep News and Research

Overactive bladder treatments: an interview with Professor Chris Chapple, Consultant Urological Surgeon at the Royal Hallamshire Hospital and Sheffield Teaching Hospitals NHS Foundation Trust

Overactive bladder symptom complex is a symptom complex, the pivotal symptom of which is urgency, which is a compelling desire to pass urine, which is difficult to defer.

1 Oct 2013

FDA approves Brintellix drug to treat depressive disorder in adults

The U.S. Food and Drug Administration today approved Brintellix (vortioxetine) to treat adults with major depressive disorder.

1 Oct 2013

Psychosomatics study shows prevalence of nightmares disorder in psychiatric patients

A study published in the current issue of psychotherapy and psychosomatics provides data concerned with the prevalence of nightmares disorder in psychiatric patients.

1 Oct 2013

Sport helps women ward off midlife sleep disturbances

Women can protect against midlife sleep disturbances by regularly exercising, findings from the Study of Women’s Health Across the Nation Sleep study show.

30 Sep 2013

Long sleep duration accelerates cognitive decline

People with long sleep durations of more than 9 hours daily have more rapid cognitive decline than those who sleep 6 to 8 hours, researchers report.

30 Sep 2013

Diabetes puts you at increased risk of flu-related complications

There are certain groups of people who are at risk of serious flu complications each year, including those with diabetes.

30 Sep 2013

Doing yoga during menopause linked to less insomnia

Taking a 12-week yoga class and practicing at home was linked to less insomnia-but not to fewer or less bothersome hot flashes or night sweats. The link between yoga and better sleep was the only statistically significant finding in this MsFLASH (Menopause Strategies: Finding Lasting Answers for Symptoms and Health) Network randomized controlled trial.

29 Sep 2013

Lumena Pharmaceuticals initiates LUM001 clinical program in children with ALGS

Lumena Pharmaceuticals, a company developing oral therapeutics for rare liver diseases, today announced the initiation of a global clinical program to evaluate its drug candidate LUM001 in children with Alagille syndrome. The first patient has been dosed in the IMAGO Phase II study being conducted in the U.K., and enrollment of pediatric patients is expected to begin later this year in the ITCH Phase II study in the U.S.

26 Sep 2013

Battle brewing over new regulations for compounding pharmacies

In addition, a bill that would require professional drivers to be tested for sleep apnea flies through the House.

25 Sep 2013

Drug to treat metastatic castration-resistant prostate cancer delays progression of pain and quality of life deterioration in men

Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone.

25 Sep 2013

Study evaluates outcomes of youth athletes after sports-related concussion

Recent scientific findings have raised the fear that young athletes may fare worse after sustaining a sports-related concussion than older athletes. Researchers from Vanderbilt University School of Medicine compared symptoms associated with concussion in middle/high school-age athletes with those in college-age athletes to determine whether age-related differences exist.

25 Sep 2013

MacLean Center receives Cornerstone Award for outstanding contributions in field of bioethics

The University of Chicago Medicine's MacLean Center for Clinical Medical Ethics has been awarded the prestigious Cornerstone Award from the American Society of Bioethics and Humanities for "outstanding contributions from an institution that has helped shape the direction of the fields of bioethics and/or medical humanities."

25 Sep 2013

First Edition: September 24, 2013

Today's headlines include reports about Senate action on the effort to defund the health law as well as a scheduled appearance by former President Bill Clinton and President Barack Obama to kick off the roll out of a key part of the overhaul.

24 Sep 2013

Caffeine intake results in delayed brain development

Humans and other mammals show particularly intensive sleeping patterns during puberty. The brain also matures fastest in this period. But when pubescent rats are administered caffeine, the maturing processes in their brains are delayed. This is the result of a study supported by the Swiss National Science Foundation (SNSF).

24 Sep 2013

Understanding genetic, physiological basis for metabolic diseases related to circadian function

A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.

24 Sep 2013

New research unveils role of ORMDL3 gene in asthma

New research from the University of Minnesota College of Veterinary Medicine has uncovered the role gene ORMDL3 plays in the disease asthma. ORMDL3, a gene recently linked to asthma susceptibility, has now been linked to the body's ability to recruit inflammatory cells during an airway allergic reaction. Study findings appear today in the journal Nature Communications.

24 Sep 2013

Parent sleep education improves daytime behavior of children with ASD

Parent sleep education is beneficial in improving sleep and aspects of daytime behavior and family functioning in children with autism spectrum disorders (ASD), according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.

24 Sep 2013

Respicardia reports results from remede System Pilot Study for central sleep apnea treatment

Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced results from the remede System Pilot Study during the Heart Failure Society of America Late Breaking Scientific Session in Orlando. Dr. William T. Abraham of The Ohio State University Wexner Medical Center in Columbus presented the results for the first and only implantable device for respiratory rhythm management to treat central sleep apnea.

24 Sep 2013

QoL questionnaire predicts nocturia, risk for falling

A study of Japanese outpatients highlights the association between nighttime voiding and bone fractures, after showing that the Nocturia Quality-of-Life questionnaire can identify patients at risk for both.

23 Sep 2013

Sleep disturbances may influence vascular cognitive decline

Patients with vascular cognitive impairment without dementia have distinct abnormal sleep patterns that may be related to their cognitive deficits, researchers report.

23 Sep 2013